Navigation Links
Micromet Expands Committed Equity Financing Facility to $75 Million
Date:12/2/2008

FF prior to the date on which the SEC declares the registration statement effective. To date, Micromet, has not drawn down any amounts under the August 2006 CEFF.

-- The maximum number of shares that Micromet can sell to Kingsbridge under the new CEFF is 10,104,919 (exclusive of shares issuable to Kingsbridge upon exercise of a warrant issued to Kingsbridge and described below), and will be reduced by any shares issued under the August 2006 CEFF prior to the date on which the SEC declares the registration statement for the new CEFF effective.

-- Micromet may access capital under the new CEFF in tranches of up to the greater of (a) a percentage of Micromet's market capitalization as determined at the time of the draw down of such tranche (which percentage ranges from 1.0% to 1.5% depending upon the Company's market capitalization at the time of the draw down) or (b) four times the average trading volume of the Company's common stock for a specified period prior to the draw down notice, multiplied by the closing price of the common stock on the trading day prior to the draw down notice, in each case subject to certain conditions, provided that the maximum amount of any tranche is limited to $10 million. Each tranche will be issued and priced over an eight-day pricing period. Kingsbridge will purchase shares of common stock pursuant to the new CEFF at discounts ranging from 6% to 14% depending on the average market price of the common stock during the eight-day pricing period, provided that if the average market price on any day during the pricing period is less than the greater of $2.00 or 85% of the closing price of the day preceding the first day of the pricing period, then such day would not be used in determining the number of shares that would be issued in the draw down and the aggregate amount of such draw down would be decreased by one-eighth.

-- Throughout the term of the agreement, Kingsbridge
'/>"/>

SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- ...armaceutical ingredients (APIs), announced that it... Safety Certification from,SafeBridge(R) Consultan...ompetency and proficiency in the safe handling of ...nd applies to specific laboratories and,production...
(Date:11/19/2009)...ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCall/ ... ABT ) as one of its Most Admired Corporate Deal... honored Abbott as its Most Admired Dealmaker in ...e of acquisitions and divestitures since January 2...ed its business portfolio with a focus on high-gro...
(Date:11/19/2009)..., Part of International Internet Week of Action ...wswire/ -- The U.S. Food and Drug Administration t...nal effort, called the International Internet Week...s involving medical products. ,, (Logo: http:/..., During the effort, the FDA,s Office of Crimin...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Clinical Trial Results of Pollogens TriPollar 28TM 29 Radio Frequency Technology published in the Journal of the European Academy of Dermatology and V 4515 1Clinical Trial Results of Pollogens TriPollar 28TM 29 Radio Frequency Technology published in the Journal of the European Academy of Dermatology and V 4515 2Most common brain cancer may start in neural stem cells 47615 1Most common brain cancer may start in neural stem cells 47615 2Most common brain cancer may start in neural stem cells 47615 3Most common brain cancer may start in neural stem cells 47615 4More stringent evaluation on the use of generic medications in thoracic transplantation 47611 1More stringent evaluation on the use of generic medications in thoracic transplantation 47611 2
... 9 /CNW/ - Insmed Inc. (NASDAQ:INSM), a ,biopharma...proval,of drugs for the treatment of metabolic di...that it will present at this,week,s C.E. Unterberg...erence in New York City. , The conference, to b... City, will run from Tuesday, July 10th through Th...
...INESS WIRE)--Jul 6, 2007 - Neurologix, Inc.,(OTCBB...elopment of,innovative gene therapies for the brai... the company will present at the Third Annual,C.E....esday July,10, 2007 at 4:30 pm ET at The Mandarin ...xecutive Officer John Mordock will discuss,Neurolo...
Other Medicine Technology:Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
(Date:11/22/2009)...21 Congressman Chaka Fa...e United States Senate,s vote tonight to proceed t..., "Senators Arlen Specter and Bob Casey deserve ...s for casting stand-up, critical votes in the Sena...fordable Health Care Reform legislation to full de...
(Date:11/21/2009)...v. 21 A regional initia...asis (river blindness) in the Americas has substan...cent years, as evidenced by a 31% decrease in the ...ration in six endemic countries. Results were rep...ican Society of Tropical Medicine and Hygiene (AST...
(Date:11/21/2009)...APPYneuron,s most popular and addictive game, Spli...uch. , Mountain View, CA ...pular and addictive game, SplitWords, is now avail...designed to help banish that ,tip of the tongue, s... game challenges the brain by encouraging users t...
(Date:11/20/2009)...Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharmaceu...g of Shareholders will be held on Monday, December...er approval of two special resolutions. The first ... sale of all or substantially all of the assets of...in the asset purchase agreement dated November 10,...
(Date:11/20/2009)..., Nov. 20 Rates of infec...ked in late October, but the pandemic flu virus co... age groups, including the elderly, according to a...E: DGX ), the world,s leading provider of diagno...its most recent Quest Diagnostics Health Trends(TM...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...ork based Columbia University Medical Center has s... some form of alcohol use disorder at some point ... the adults surveyed reported experiencing alcohol...f the JAMA/Archives journals, states that alcohol ...
...e for 1,000 pounds a measure. Available at...he rare Johnnie Walker 1805 has just gone on sale....200 bottles have been made to celebrate the birthd...distilleries which have since shut down. None of t...
...in sickness (AMS), which affects about half of tho...life-threatening complications such as pulmonary o...al public in AMS is thought to have increased over...rent changes, it is unknown whether there is an ac...
... a British Youngman willingly came forward to dona...the transplant has been successful. Da...re speaking after The 20-year-old David Lomas from... at first and I thought he meant he wanted me to g...
...ion of 2003 have not absorbed dangerous levels of ...f print in Occupational and Environmental Medicine...mbat to pierce armoured vehicles, and spontaneousl...essed many years after potential exposure, using a...
...earchers at Northwestern University has shown that...onsecutive days, they no longer attempt to catch u... The study suggests that repeated partial s...s to acute sleep loss. Published in the Pr...
Other Medicine News:Health News:One-third of Adults Have Had Some Form of Alcohol Use Disorder During Their Lifetimes 2Health News:Scot's National Drink, Now Available at 1,000 Pounds a Nip 2Health News:Acute Mountain Sickness may Lead to Pulmonary or Cerebral Edema 2Health News:Son Donates Part of Liver to Ailing Father, Transplant Successful 2Health News:Lost Sleep can Never Be Compensated for 2
...he only MR contrast agent FDA-approved for adminis...um based, IV contrast media for MR imaging of the ...ackaging options for just the right amount of cont...y. You can trust OptiMARK for the tolerability an...
...MNISCAN was launched in the U.S. in 1993 to provid...em (CNS) to detect lesions of the brain, spinal co...eived approval for adult body and high-dose CNS in... OMNISCAN comes in different sizes to accommodate ...
SonoVue®
Ultravist
Medicine Products: